Future Directions for HIV/HCV Care: Lessons Learned From Local Evaluation Projects in Texas and Connecticut and Implications for Practice and Health Promotion

Abstract

The Health Resources Service Administration (HRSA) Special Projects of National Significance (SPNS) project titled “Curing Hepatitis C among People of Color Living with HIV,” funded two sites, University of Texas (TX) San Antonio and Yale University School of Medicine in Connecticut (CT) to explore barriers and facilitators towards achieving HCV cure in the era of curative DAAs for HCV in different local contexts. Through individualized approaches that study patient, provider and system level barriers, the nine articles in this Focus Issue highlight key themes that are important in designing local implementation strategies that will enable achievement of HCV elimination goals in priority populations.

Keywords

HIV hepatitis C HIV/HCV coinfection barriers to care health education care cascades

Get full access to this article

View all access options for this article.

References

Allison

Choi

Kawasaki

Desai

Melhado

(2023a). Accessing care during the COVID-19 pandemic using telemedicine: Perspective from people with HIV (PWHIV). Health Promotion Practice, 24(5), 1050-1054. https://doi.org/10.1177/15248399231169919

Allison

Choi

Kawasaki

Desai

Tsevat

Melhado

(2023b). An assessment of hepatitis C (HCV) knowledge, attitudes, and perceptions among people with HIV in the Southern United States. Health Promotion Practice, 24(5), 1050-1054. https://doi.org/10.1177/15248399231169919

Allison

Desai

Kawasaki

Choi

Bobadilla

Melhado

Taylor

(2023c). Qualitative evaluation of a program to integrate hepatitis C (HCV) care into HIV care inclusive of task shifting to non-specialist providers. Health Promotion Practice, 24(5), 1050-1054. https://doi.org/10.1177/15248399231169919

Allison

Prasana

Choi

Kawasaki

Desai

Melhado

(2023d). Mitigating the HIV and viral hepatitis workforce crisis through development of an HIV/hepatitis C co-infection mobile application. Health Promotion Practice, 24(5), 1050-1054. https://doi.org/10.1177/15248399231169919

Bosh

K. A.

Coyle

J. R.

Hansen

Kim

E. M.

Speers

Comer

Maddox

L. M.

Khuwaja

Zhou

Jatta

Mayer

Brantley

A. D.

Muriithi

N. W.

Bhattacherjee

Flynn

Bouton

John

Keusch

Barber

C. A.

. . .Hall

H. I.

(2018). HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities. Epidemiology and Infection, 146(7), 920–930. https://doi.org/10.1017/S0950268818000766

Brooks

Wegener

Freeman

Fowles

Madden

Tetrault

Nichols

Altice

Villanueva

(2023a). Improving HIV and HCV testing in substance use disorder programs (SUDs) that provide medication for opiate use disorder (MOUD): Role of addressing barriers and implementing universal and site-specific approaches. Health Promotion Practice, 24(5), 1050-1054. https://doi.org/10.1177/15248399231169919

Brooks

Wegener

Speers

Nichols

Sideleau

Valeriano

Buchelli

Villanueva

(2023b). Creating a multi-site HCV care cascade for persons with HIV/HCV co-infection in selected HIV clinics using data to care methods. Health Promotion Practice, 24(5), 1050 -1054. https://doi.org/10.1177/15248399231169919

Cepeda

J. A.

Thomas

D. L.

Astemborski

Rudolph

J. E.

Gicquelais

Kirk

G. D.

Mehta

S. H.

(2022). Impact of hepatitis C treatment uptake on cirrhosis and mortality in persons who inject drugs: A longitudinal, community-based cohort study. Annals of Internal Medicine, 175(8), 1083–1091. https://doi.org/10.7326/M21-3846

Connecticut Department of Public Health. (2020). HIV surveillance report. https://portal.ct.gov/DPH/AIDS—Chronic-Diseases/Surveillance/HIV-Surveillance-Program

10.

Didomizio

Chandra

Nichols

Villanueva

Altice

(2023). Challenges to achieving HCV micro-elimination in people with HIV in the United States: Provider perspectives and the role of implicit bias. Health Promotion Practice, 24(5), 1050-1054. https://doi.org/10.1177/15248399231169919

11.

Hao

Brooks

Zelenev

Spinner

Barakat

Villanueva

(2023). Expanded or risk-factor based annual screening for hepatitis C virus (HCV) among persons with HIV: Which is the best approach? Health Promotion Practice, 24(5), 1050-1054. https://doi.org/10.1177/15248399231169919

12.

Health Resources and Services Administration. (2020). Optimizing HIV care for people aging with HIV: Incorporating new elements of care: A reference guide for aging with HIV. https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/grants/aging-guide-new-elements.pdf

13.

HepVu.org. (2023). Understanding hepatitis C in your state. https://hepvu.org

14.

Hofmeister

M. G.

Rosenthal

E. M.

Barker

L. K.

Rosenberg

E. S.

Barranco

M. A.

Hall

E. W.

Edlin

B. R.

Mermin

Ward

J. W.

Ryerson

A. B.

(2019). Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016. Hepatology, 69(3), 1020–1031. https://doi.org/10.1002/hep.30297

15.

Texas Department of State Health Services. (2019). HIV and hepatitis surveillance data. https://www.dshs.texas.gov/hiv-std-program/hiv-aids-std-information/hepatitis-c/hepatitis-c-data

16.

World Health Organization. (2021). Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021—Accountability for the global health sector strategies 2016-2021: Actions for impact. https://www.who.int/publications/i/item/9789240027077

17.

Zhao

Wegener

Brooks

Mininberg

Helou

Maughan

Villanueva

(2023). Characterizing persons with HIV/HCV coinfection who remain untreated for hepatitis C at four HIV clinics in Connecticut (CT): Role of multiple overlapping barriers at the individual and clinic system level. Health Promotion Practice, 24(5), 1050-1054. https://doi.org/10.1177/15248399231169919